News & Events

NEWS
Press-Release
September 28, 2017
Computer model showed an optimal anti-amyloid treatment
Moscow, Russia, September 28, 2017. One must activate amyloid degradation as soon as possible to prevent the appearance of the protein plaques in brain under Alzheimer’s conditions. This conclusion was reached by scientists from the biotechnology company InSysBio, who created the first computer model of the disease. The final part of the work has been recently published in CPT: Pharmacometrics & Systems Pharmacology.
LEARN MORE
NEWS
Press-Release
July 25, 2017
InSysBio LLC Announce Renewal of Agreement with ASTEX Pharmaceuticals Inc.
Moscow, Russia, July 25, 2017 – InSysBio LLC (www.insysbio.ru), one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a renewal of multi-year Master Service Agreement with ASTEX Pharmaceuticals, Inc.
LEARN MORE
July 2026
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
1. 07 Jul 2026 15:29 InSysBio to participate in UK-QSP Training Workshop 2026 InSysBio announces its participation in UK-QSP Training Workshop 2026 which is to be held from July 8-10, 2026 at the University of Warwick, UK. Ivan Borisov, Senior Software Developer, InSysBio, will present a poster, titled "Mixed-Integer Optimization for Virtual Population Selection in QSP" and give a talk
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
  
Upcoming Events
10.08
InSysBio to take part in JuliaCon 2026
Tags